---
title: "NervGen Pharma 宣布将参加投资者会议，首席执行官 Adam Rogers 将出席。TSXV: NGEN, NASDAQ: NGEN"
description: "NervGen Pharma Corp.是一家总部位于不列颠哥伦比亚省温哥华的生物制药公司，今天透露其总裁兼首席执行官 Adam Rogers 博士以及其他高管将在不久的将来参加各种投资者会议。该公司在 TSXV（股票代码为 NGEN）和 NASDAQ（同样的股票代码）上市，专注于开发脊髓损伤和其他神经创伤性疾病的创新治疗方案。此公告于 2026 年 2 月 18 日发布"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276229460.md"
published_at: "2026-02-18T12:32:37.000Z"
---

# NervGen Pharma 宣布将参加投资者会议，首席执行官 Adam Rogers 将出席。TSXV: NGEN, NASDAQ: NGEN

> NervGen Pharma Corp.是一家总部位于不列颠哥伦比亚省温哥华的生物制药公司，今天透露其总裁兼首席执行官 Adam Rogers 博士以及其他高管将在不久的将来参加各种投资者会议。该公司在 TSXV（股票代码为 NGEN）和 NASDAQ（同样的股票代码）上市，专注于开发脊髓损伤和其他神经创伤性疾病的创新治疗方案。此公告于 2026 年 2 月 18 日发布

总部位于不列颠哥伦比亚省温哥华的生物制药公司 NervGen Pharma Corp.今天透露，其总裁兼首席执行官 Adam Rogers 博士以及其他高管将在不久的将来参加多个投资者会议。该公司在 TSXV（股票代码 NGEN）和 NASDAQ（同样的股票代码）上市，专注于开发脊髓损伤和其他神经创伤性疾病的创新治疗方案。此公告于 2026 年 2 月 18 日发布。

### Related Stocks

- [NGEN.US - NervGen Pharma](https://longbridge.com/zh-CN/quote/NGEN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| NervGen Pharma Reports Positive Results from Phase 1b/2a CONNECT Study in Chronic Spinal Cord Injury | NervGen Pharma Corp. announced positive results from its Phase 1b/2a CONNECT Study for chronic spinal cord injury. The c | [Link](https://longbridge.com/zh-CN/news/275600172.md) |
| NervGen Pharma ernennt Adam Rogers zum CEO | NervGen Pharma Corp. has appointed Adam Rogers, MD, as the new President and Chief Executive Officer, effective immediat | [Link](https://longbridge.com/zh-CN/news/275312873.md) |
| 08:57 ETValinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development | Valinor Discovery and Renew Biotechnologies have announced a strategic partnership to create the largest clinical multi- | [Link](https://longbridge.com/zh-CN/news/276745533.md) |
| AlzeCure Pharma Pain Project ACD440 Gets Orphan Drug Status In EU | AlzeCure Pharma AB :PAIN PROJECT ACD440 GRANTED ORPHAN DRUG STATUS IN THE EU | [Link](https://longbridge.com/zh-CN/news/276726632.md) |
| More Than 30 Million Americans Living with Rare Diseases | The National Organization for Rare Disorders (NORD) highlights the challenges faced by over 30 million Americans living  | [Link](https://longbridge.com/zh-CN/news/276632841.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。